Publication: Orlistat is a fatty acid synthase (FASN) inhibitor caused the modulation of AMPK and lipogenesis signaling axis in PC3 prostate cancer cells but not in PNT1A prostate epithelial cells
Program
Authors
Nebiler, E.
Adacan, K.
Çoker Gürkan, Ajda
Palavan Ünsal, Zeynep Narçın
